Quince Therapeutics (QNCX) Discusses On Red Blood Cell Drug Delivery Platform And Focus On Ataxia Telangiectasia In Phase III Trials Transcript

Discover Quince Therapeutics’ breakthrough drug-delivery platform aiming to safely treat rare diseases with encapsulated steroids.
C&EN

Allosteric Inhibition of PTP1B by a Nonpolar Terpenoid

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to ...

High-Purity Solvents Market Analysis 2025: Opportunities for the $45 Billion Industry by 2030: Insights by Type, Grade, Category, Application, End Use and Region

The high-purity solvents market is poised for growth due to increasing demand in pharmaceuticals, biotech, and electronics, ...